Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Mol Cancer Ther. 2010 Dec;9(12):3105–3114. doi: 10.1158/1535-7163.MCT-10-0674

Table 4.

MicroRNA correlations

FdUMP[10] 5FU FdU Topotecan Irinotecan
Hsa-miR-224 −0.321 nd2 nd nd nd
Hsa-miR-23a* 0.36 nd1 0.35 0.48 0.41
Hsa-miR-24 nd1 −0.31 −0.29 −0.32 −0.43
hsa-miR-24-1* −0.31 nd nd nd nd
hsa-miR-324-3p 0.37 nd 0.34 0.44 0.38
hsa-miR-455-3p 0.36 nd 0.26 nd nd
hsa-miR-500 0.38 nd 0.37 0.48 0.43
hsa-miR-501-5p 0.37 0.26 0.35 0.48 0.41
hsa-miR-650 0.35 nd 0.38 0.43 0.46
hsa-miR-874 0.36 nd 0.40 0.43 0.49
hsa-miR-1226* 0.37 0.32 0.40 0.44 0.44
1

Negatively significant correlations are underlined.

2

“nd” indicates that thecorrelation was less than cutoff (+/− 0.25).